Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| type I pneumocyte | 12 studies | 47% ± 17% | |
| fibroblast | 9 studies | 36% ± 10% | |
| smooth muscle cell | 8 studies | 28% ± 9% | |
| type II pneumocyte | 7 studies | 42% ± 13% | |
| myofibroblast cell | 6 studies | 27% ± 5% | |
| podocyte | 5 studies | 63% ± 27% | |
| mesothelial cell | 5 studies | 30% ± 12% | |
| club cell | 4 studies | 43% ± 17% | |
| astrocyte | 4 studies | 30% ± 6% | |
| basal cell | 3 studies | 30% ± 16% | |
| renal alpha-intercalated cell | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 31% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 33657.01 | 652 / 653 | 96% | 320.17 | 583 / 605 |
| prostate | 93% | 6823.58 | 228 / 245 | 99% | 111.46 | 496 / 502 |
| lung | 100% | 18633.86 | 577 / 578 | 68% | 37.41 | 791 / 1155 |
| kidney | 100% | 9380.08 | 89 / 89 | 59% | 32.81 | 528 / 901 |
| pancreas | 76% | 2076.88 | 248 / 328 | 80% | 47.61 | 142 / 178 |
| uterus | 82% | 2783.94 | 140 / 170 | 67% | 41.42 | 307 / 459 |
| breast | 54% | 2192.77 | 250 / 459 | 84% | 120.39 | 934 / 1118 |
| intestine | 57% | 2428.73 | 554 / 966 | 71% | 31.01 | 375 / 527 |
| esophagus | 61% | 3566.82 | 876 / 1445 | 61% | 30.68 | 111 / 183 |
| ureter | 0% | 0 | 0 / 0 | 100% | 27.98 | 1 / 1 |
| blood vessel | 100% | 17894.99 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 34% | 999.45 | 121 / 359 | 58% | 27.13 | 167 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 78% | 54.67 | 35 / 45 |
| bladder | 38% | 803.62 | 8 / 21 | 34% | 14.58 | 173 / 504 |
| adipose | 60% | 2328.02 | 725 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 42% | 1212.75 | 101 / 241 | 0% | 0 | 0 / 0 |
| ovary | 22% | 925.46 | 39 / 180 | 19% | 6.76 | 83 / 430 |
| brain | 7% | 191.77 | 176 / 2642 | 25% | 14.80 | 173 / 705 |
| liver | 0% | 0 | 0 / 226 | 17% | 11.85 | 69 / 406 |
| adrenal gland | 4% | 94.97 | 11 / 258 | 9% | 4.39 | 21 / 230 |
| skin | 8% | 216.49 | 153 / 1809 | 1% | 0.57 | 6 / 472 |
| heart | 2% | 55.58 | 21 / 861 | 0% | 0 | 0 / 0 |
| muscle | 2% | 47.48 | 16 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 2% | 42.43 | 15 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030511 | Biological process | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO_0001657 | Biological process | ureteric bud development |
| GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
| GO_0033631 | Biological process | cell-cell adhesion mediated by integrin |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0045184 | Biological process | establishment of protein localization |
| GO_0010811 | Biological process | positive regulation of cell-substrate adhesion |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0097195 | Biological process | pilomotor reflex |
| GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
| GO_0071356 | Biological process | cellular response to tumor necrosis factor |
| GO_0045987 | Biological process | positive regulation of smooth muscle contraction |
| GO_0051145 | Biological process | smooth muscle cell differentiation |
| GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
| GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005576 | Cellular component | extracellular region |
| GO_0016020 | Cellular component | membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0030485 | Cellular component | smooth muscle contractile fiber |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005604 | Cellular component | basement membrane |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0005178 | Molecular function | integrin binding |
| GO_0005509 | Molecular function | calcium ion binding |
| Gene name | NPNT |
| Protein name | Nephronectin (Preosteoblast EGF-like repeat protein with MAM domain) (Protein EGFL6-like) Nephronectin |
| Synonyms | UNQ295/PRO334 EGFL6L POEM |
| Description | FUNCTION: Functional ligand of integrin alpha-8/beta-1 in kidney development. Regulates the expression of GDNF with integrin alpha-8/beta-1 which is essential for kidney development. May also play a role in the development and function of various tissues, regulating cell adhesion, spreading and survival through the binding of several integrins (By similarity). . |
| Accessions | D6RE63 ENST00000453617.6 [Q6UXI9-6] ENST00000506666.5 [Q6UXI9-4] ENST00000427316.6 [Q6UXI9-3] H0YA60 H0YAK9 ENST00000379987.7 [Q6UXI9-1] ENST00000504304.5 Q6UXI9 ENST00000514622.5 [Q6UXI9-5] ENST00000504787.1 ENST00000503451.5 ENST00000505917.1 ENST00000514837.1 D6RH31 H0Y8M1 ENST00000305572.12 [Q6UXI9-2] |
